S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Prologis Stock Leading U.S. Logistics Boom
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Prologis Stock Leading U.S. Logistics Boom
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Prologis Stock Leading U.S. Logistics Boom
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Prologis Stock Leading U.S. Logistics Boom
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
NASDAQ:NARI

Inari Medical (NARI) Stock Price, News & Analysis

$38.70
-0.40 (-1.02%)
(As of 05:27 PM ET)
Today's Range
$38.47
$39.78
50-Day Range
$39.10
$59.03
52-Week Range
$38.35
$71.85
Volume
656,962 shs
Average Volume
1.14 million shs
Market Capitalization
$2.24 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$73.71

Inari Medical MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
89.0% Upside
$73.71 Price Target
Short Interest
Bearish
8.06% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.13mentions of Inari Medical in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$1.89 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.39) to $0.37 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.09 out of 5 stars

Medical Sector

550th out of 914 stocks

Surgical & Medical Instruments Industry

60th out of 94 stocks

NARI stock logo

About Inari Medical Stock (NASDAQ:NARI)

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

NARI Stock Price History

NARI Stock News Headlines

Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Inari Medical Shares Gain After Index Move
Forecasting The Future: 7 Analyst Projections For Inari Medical
NARI Apr 2024 65.000 call
Inari Medical CFO sells shares worth over $250k
See More Headlines
Receive NARI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inari Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
4/17/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NARI
Fax
N/A
Employees
1,300
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$73.71
High Stock Price Target
$100.00
Low Stock Price Target
$52.00
Potential Upside/Downside
+88.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Net Income
$-1,640,000.00
Pretax Margin
0.86%

Debt

Sales & Book Value

Annual Sales
$493.63 million
Cash Flow
$0.09 per share
Book Value
$8.07 per share

Miscellaneous

Free Float
51,817,000
Market Cap
$2.27 billion
Optionable
Optionable
Beta
0.84
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives


NARI Stock Analysis - Frequently Asked Questions

Should I buy or sell Inari Medical stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Inari Medical in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NARI shares.
View NARI analyst ratings
or view top-rated stocks.

What is Inari Medical's stock price target for 2024?

6 brokers have issued twelve-month target prices for Inari Medical's stock. Their NARI share price targets range from $52.00 to $100.00. On average, they predict the company's stock price to reach $73.71 in the next twelve months. This suggests a possible upside of 89.0% from the stock's current price.
View analysts price targets for NARI
or view top-rated stocks among Wall Street analysts.

How have NARI shares performed in 2024?

Inari Medical's stock was trading at $64.92 at the start of the year. Since then, NARI shares have decreased by 39.9% and is now trading at $39.01.
View the best growth stocks for 2024 here
.

When is Inari Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our NARI earnings forecast
.

How were Inari Medical's earnings last quarter?

Inari Medical, Inc. (NASDAQ:NARI) posted its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of $0.01 by $0.09. The company earned $132.10 million during the quarter, compared to analysts' expectations of $131.82 million. Inari Medical had a negative net margin of 0.33% and a positive trailing twelve-month return on equity of 1.23%. Inari Medical's revenue for the quarter was up 22.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.11) earnings per share.

What guidance has Inari Medical issued on next quarter's earnings?

Inari Medical issued an update on its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $580.0 million-$595.0 million, compared to the consensus revenue estimate of $588.3 million.

What other stocks do shareholders of Inari Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inari Medical investors own include NVIDIA (NVDA), Home Depot (HD), CVS Health (CVS), QUALCOMM (QCOM), Thermo Fisher Scientific (TMO), Johnson & Johnson (JNJ), Alibaba Group (BABA), Procter & Gamble (PG) and Bristol-Myers Squibb (BMY).

When did Inari Medical IPO?

Inari Medical (NARI) raised $110 million in an IPO on Friday, May 22nd 2020. The company issued 7,300,000 shares at $14.00-$16.00 per share. BofA Securities and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and Wells Fargo Securities were co-managers.

How do I buy shares of Inari Medical?

Shares of NARI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NARI) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners